AZN.L vs. LCJP.L
AZN.L (AstraZeneca plc) is a stock, while LCJP.L (Amundi MSCI Japan UCITS ETF Acc) is Japan Equities fund tracking the TOPIX TR JPY. Over the past 5 years, AZN.L returned 13.33%/yr vs 10.26%/yr for LCJP.L. At a 0.28 correlation, their price movements are largely independent.
Performance
AZN.L vs. LCJP.L - Performance Comparison
Loading charts...
Different Trading Currencies
AZN.L is traded in GBp, while LCJP.L is traded in GBP. To make them comparable, the LCJP.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, AZN.L achieves a -0.69% return, which is significantly lower than LCJP.L's 16.47% return.
AZN.L
- 1D
- 2.60%
- 1M
- -0.09%
- YTD
- -0.69%
- 6M
- 0.75%
- 1Y
- 28.88%
- 3Y*
- 6.86%
- 5Y*
- 13.33%
- 10Y*
- 16.08%
LCJP.L
- 1D
- -0.28%
- 1M
- 6.27%
- YTD
- 16.47%
- 6M
- 15.66%
- 1Y
- 34.33%
- 3Y*
- 15.67%
- 5Y*
- 10.26%
- 10Y*
- —
AZN.L vs. LCJP.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AZN.L AstraZeneca plc | -0.69% | 34.59% | 0.92% | -3.53% | 32.32% | 21.78% | -0.99% | 33.98% | 22.91% |
LCJP.L Amundi MSCI Japan UCITS ETF Acc | 16.47% | 17.61% | 8.90% | 14.05% | -7.13% | 2.24% | 12.26% | 14.63% | -4.50% |
Correlation
The correlation between AZN.L and LCJP.L is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Mar 23, 2018 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AZN.L vs. LCJP.L — Risk / Return Rank
AZN.L
LCJP.L
AZN.L vs. LCJP.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca plc (AZN.L) and Amundi MSCI Japan UCITS ETF Acc (LCJP.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AZN.L | LCJP.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.70 | ||
| Sortino ratioReturn per unit of downside risk | -0.67 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.35 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 1.86 | 3.21 | -1.35 |
| Martin ratioReturn relative to average drawdown | 4.85 | 10.25 | -5.39 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AZN.L | LCJP.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 1.84 | -0.70 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.56 | 0.64 | -0.08 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.66 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.53 | 0.52 | +0.01 |
Drawdowns
AZN.L vs. LCJP.L - Drawdown Comparison
The maximum AZN.L drawdown since its inception was -49.99%, which is greater than LCJP.L's maximum drawdown of -26.61%. Use the drawdown chart below to compare losses from any high point for AZN.L and LCJP.L.
Loading charts...
Drawdown Indicators
| AZN.L | LCJP.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.99% | -26.61% | -23.38% |
Max Drawdown (1Y)Largest decline over 1 year | -15.00% | -10.64% | -4.36% |
Max Drawdown (3Y)Largest decline over 3 years | -26.75% | -14.62% | -12.13% |
Max Drawdown (5Y)Largest decline over 5 years | -26.75% | -18.58% | -8.17% |
Max Drawdown (10Y)Largest decline over 10 years | -26.75% | — | — |
Current DrawdownCurrent decline from peak | -12.79% | -0.28% | -12.51% |
Average DrawdownAverage peak-to-trough decline | -11.69% | -5.49% | -6.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.77% | 3.34% | +2.43% |
Volatility
AZN.L vs. LCJP.L - Volatility Comparison
AstraZeneca plc (AZN.L) has a higher volatility of 6.10% compared to Amundi MSCI Japan UCITS ETF Acc (LCJP.L) at 3.73%. This indicates that AZN.L's price experiences larger fluctuations and is considered to be riskier than LCJP.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AZN.L | LCJP.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 3.73% | +2.37% |
Volatility (6M)Calculated over the trailing 6-month period | 16.92% | 15.10% | +1.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.50% | 18.58% | +5.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.76% | 15.97% | +7.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.32% | 16.82% | +7.50% |
Dividends
AZN.L vs. LCJP.L - Dividend Comparison
AZN.L's dividend yield for the trailing twelve months is around 1.74%, while LCJP.L has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN.L AstraZeneca plc | 1.74% | 1.77% | 2.23% | 2.21% | 1.98% | 2.33% | 2.95% | 2.87% | 3.44% | 4.28% | 4.50% | 3.95% |
LCJP.L Amundi MSCI Japan UCITS ETF Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
AZN.L and LCJP.L have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for AZN.L and LCJP.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer